Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cemiplimab
Related studies linked through entity extraction aliases.
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
- Status
- RECRUITING
- Phase
- PHASE1
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
- Status
- SUSPENDED
- Phase
- PHASE3
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2